Placebo rates in randomized controlled trials of proctitis therapy: A systematic review and meta-analysis.
Fiche publication
Date publication
août 2022
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
De Silva TA, Alphonsus L, Ma C, Hogan M, Sedano R, Narula N, Danese S, Peyrin-Biroulet L, MacDonald JK, Singh S, Jairath V
Lien Pubmed
Résumé
Treatment options for proctitis are limited. To assist trial design for novel therapeutics, we conducted a systematic review and meta-analysis of proctitis randomized controlled trials (RCTs) to quantify placebo rates and identify factors influencing them.
Mots clés
Clinical trials, Placebo, Proctitis
Référence
J Crohns Colitis. 2022 08 5;: